key: cord-0875774-xxur81c4 authors: Teasdale, Chloe A.; Borrell, Luisa N.; Kimball, Spencer; Rinke, Michael L.; Rane, Madhura; Fleary, Sasha A.; Nash, Denis title: Plans to Vaccinate Children for COVID-19: A Survey of Us Parents date: 2021-07-18 journal: J Pediatr DOI: 10.1016/j.jpeds.2021.07.021 sha: a328eb292df81c29c26ac87859b728d0c13b0cfd doc_id: 875774 cord_uid: xxur81c4 In a national survey of 2,074 US parents of children <12 years old conducted in March 2021, 49.4% reported plans to vaccinate their child for COVID-19 when available. Lower income and less education were associated with greater parental vaccine hesitancy/resistance; safety and lack of need were primary reasons for vaccine hesitancy/resistance. In a national survey of 2,074 US parents of children <12 years old conducted in March 2021, 49.4% reported plans to vaccinate their child for COVID-19 when available. Lower income and less education were associated with greater parental vaccine hesitancy/resistance; safety and lack of need were primary reasons for vaccine hesitancy/resistance. As of June 2021, more than 4 million US children have been diagnosed with COVID-19 and over 300 have died. 1 Although children are less likely to experience severe disease and mortality from COVID-19 infection compared with adults, younger children, those with underlying health conditions and from communities disproportionately affected by the COVID-19 epidemic are vulnerable to severe disease. [2] [3] [4] [5] [6] In addition, COVID-19 infection can lead to multi-inflammatory syndrome in children (MIS-C) and there is some evidence that children may experience long COVID with ongoing symptoms, including fatigue and pain. [7] [8] [9] To date, mask wearing and social distancing, including closing or reducing time at school, have been the primary approaches for infection control in children. 10, 11 Although no COVID- 19 vaccines are yet approved for children <12 years of age (as of June 2021), clinical trials in younger pediatric populations are underway. 12 Once vaccines are available for use in children, parental willingness to vaccinate will be needed to protect children from COVID-19 infection, reducing risk in schools, increasing population immunity levels and ending the epidemic. [13] [14] [15] A safe and effective vaccine will allow children to return to normal activities, and help relieve the social isolation as well as other negative impacts the epidemic has had on children's mental health and well-being. 16, 17 It is estimated that more than two thirds of the US population will need to be vaccinated to end sustained transmission of COVID-19. 18, 19 In a survey of US adults conducted in March 2021, J o u r n a l P r e -p r o o f more than 60% had either received vaccination or were planning to receive it. 20 According to the Centers for Disease Control and Prevention's COVID Data Tracker, by the middle of June 2021, more than 175 million or 53% of adults in the US had received at least one dose of an approved COVID-19 vaccine. 21 There is limited evidence on the extent to which parents intend to vaccinate their children for COVID-19 when a pediatric vaccine is available. We report findings from a national survey measuring plans among US parents of children <12 years to vaccinate their children against COVID-19, reasons for parents not wanting to vaccinate children and the relationship between a parent's own vaccination status and their plans to vaccinate their child. We conducted a community-based, non-probability survey of English and Spanish speaking US parents and caregivers ('parents') of children <12 years of age using a panel recruited online by Qualtrics, an online platform that sources participants through social media and partner networks. Adults >18 years who identified as primary caregivers of a child <12 years who had taken a child for >1 medical visit in the past 2 years were eligible. Data were collected from March 9 through April 2, 2021. The target sample size was 2,000 to obtain precise and reliable estimated differences between race/ethnicity groups; the final sample included 2,074 eligible US parent/caregivers of children <12 years. Participants completed surveys using their electronic devices and no incentives were provided. After completing screening questions, eligible participants reported information for the youngest child in the household (to achieve an adequate sample of younger children) and provided socio-demographic data about themselves and their household. Quota-sampling and survey weighting were based on sex, race, ethnicity, education and region and designed to provide national estimates of US parents of children <12 years according to J o u r n a l P r e -p r o o f 4 2019 US Census data. 22 We followed the American Association for Public Opinion Research (AAPOR) guidelines for reporting opt-in non-probability panel data, for which participation rates cannot be estimated as the sampling frame is unknown. 23 Ethics approval was received from the CUNY School of Public Health and Health Policy institutional review board. The outcome was specified as the proportion of parents reporting that they want to vaccinate the youngest child in the household. Participants were asked "when a vaccine to prevent COVID-19 is approved for children, would you want your child to receive the vaccine", with response options "yes", "no" and "unsure". (Supplementary material) Those responding "no" or "unsure" were asked "why do you not want your child to receive the COVID-19 vaccine?" and could choose multiple options including, "I have concerns about safety and effectiveness of the vaccine for children" and "I believe children are at low risk for infection so they do not need a vaccine.". In addition to reporting demographics and household data, parents reported whether they had received or plan to get the COVID-19 vaccine themselves with responses options including already received COVID-19 vaccination, plan to receive when available, unsure, will not get the vaccine and prefer not to answer. Descriptive statistics on the total sample population and prevalence estimates are presented according to vaccination plans (Yes, No, Unsure). Rao-Scott adjusted Pearson chi-square tests were used to compare parental vaccination plans according to sample characteristics. Poisson regression models with robust standard errors were fitted to estimate prevalence ratios (PR) and their confidence intervals (CI) comparing parents planning to vaccinate to those responding "no" or "unsure" (combined) and were adjusted for demographic and household characteristics. Parental vaccination status was examined as three groups: (1) parents responding they had J o u r n a l P r e -p r o o f already received vaccination and those who planned to receive vaccination, (2) parents responding they were unsure and the few who preferred not to answer; and (3) those who reported they would not get vaccinated. We examined the association between parental vaccine status with reported intentions to vaccinate children using Rao-Scott adjusted Pearson chi-square tests to compare proportions. All analyses were weighted to provide national estimates. Sample sizes presented in the Table I were unweighted, but all other estimates (proportions and PRs with their 95% CIs) were weighted. Analyses were conducted in SAS 9.4 (SAS Institute Inc, Cary, NC, USA). Among 2,074 US parents surveyed, 49.4% said they intended to vaccinate the youngest child in their household (median child age: 4.8 years; interquartile range: 4.5-5.1) for COVID-19 when a pediatric vaccine is approved, 25.6% said they would not and 25.0% said they were unsure (Table 1 ). Among parents responding that they would not or were unsure whether they would vaccinate their child, 78.2% reported potential safety or effectiveness concerns, 23.0% reported that they did not believe children need to be vaccinated, and 8.5% and 11.2% reported religious or medical reasons, respectively. In adjusted models, Asian parents were 38% more likely to report intentions to vaccinate their children compared with non-Hispanic Whites (adjusted PR [aPR]: 1.38;95% CI: 1.19-1.60) ( Among parents reporting that they had gotten or would get vaccinated, 85.2% said they would get their child vaccinated for COVID-19, 10.0% said they were unsure and 4.8% reported they would not vaccinate their child. Parents who were unsure or did not plan to vaccinate themselves were much less likely to report wanting to vaccinate their children: 19.5% of parents who were unsure about getting vaccinated themselves said they would vaccinate their child, 60.4% were unsure about vaccinating a child and 20.1% said they would not. Only 5.7% of parents who said they would not get vaccinated themselves reported planning to vaccinate their child, 15.6% were unsure and 78.8% said they would not vaccinate their child (p<0.0001) (Figure) . As of March 2021, only one-half of US parents reported plans to have their youngest child receive a COVID-19 vaccine when they become available for pediatric populations. The primary concerns reported by parents were safety and effectiveness, as well as perceived lack of need. Female parents, those with less education and lower income were least likely to report plans to vaccinate their children. We observed a strong association between a parent's own vaccination status or hesitancy with hesitancy to vaccinate their child when a pediatric vaccine is available. These findings have important implication for pediatric vaccine policies and roll-out planning over the coming months. Our findings showing only one-half of parents reporting they will vaccinate their child, and 26% saying they will not, are concerning given the estimated vaccination coverage required to reach herd immunity. 18, 19 There are few data with which to compare our findings regarding intentions among US parents to vaccinate their children for COVID-19. Therefore, our findings provide information with regard to the current state of willingness, as well as the characteristics of parents who are hesitant. We found that, similar to previous studies of other childhood vaccinations, lower parental education was a predictor of vaccine hesitancy. 24, 25 Our findings also suggest that although Asian parents report being more likely to report wanting to vaccinate their child, female parents and those with lower education were less likely to want their child to receive COVID-19 vaccines. 26 These findings provide information that can be used to inform strategies to increase awareness about COVID-19 vaccination for children to increase uptake when available. The majority of parents surveyed who reported they will not or are unsure whether they will vaccinate their child cited safety and effectiveness as the primary reason (78%) and almost a quarter reported that children are at low risk for COVID-19 infection and do not need to be vaccinated. These findings are consistent with a previous report of vaccine hesitancy for routine childhood immunization and influenza where safety and lack of perceived susceptibility are the main reasons for delaying or not accepting vaccination. 27 Our findings suggest that providing evidence of the safety of COVID-19 vaccination will be important for increasing uptake, as well as educating parents about the importance of vaccination for children. Approximately 50% of parents in our survey reported that they already had or planned to get vaccinated for COVID-19 which is somewhat lower than a poll conducted among all US adults by Kaiser News Network (also conducted in March 2021) which included more older adults J o u r n a l P r e -p r o o f compared with our sample. 20 Studies in US adults have also shown more vaccine hesitancy among females which was consistent with our findings that female parents were less likely to report wanting to vaccinate their child. 26 We also found a strong correlation between parental vaccination status/hesitancy and plans for vaccinating the child. These findings could suggest that an additional benefit of increasing adult vaccination coverage may be increased uptake for children; however, this requires further study. There are several limitations to our analysis. Our survey focused on children 12 years of age and younger to collect information about younger children but we therefore do not have data on adolescents. The survey data are self-reported, and thus, subject to recall, response, and social desirability bias. In addition, although our survey used quota-based sampling and was weighted to reflect the US population of parents based on 2019 census estimates, it was conducted online and recruited through panels. Parents without access to the internet were not able to participate and thus, our findings may not fully reflect the US parent population. Nevertheless, our survey followed best practices for recruitment and representation of non-probability online samples using validated approaches. 28 Finally, our survey was conducted prior to the pause of the Johnson & Johnson vaccine distribution due to safety concerns which may be contributing to increased vaccine hesitancy. 29 Overall, our findings suggest that targeted efforts will be needed to ensure high uptake and coverage of COVID-19 vaccination in US children. 14 They also show that providing evidence of the safety of vaccines and educating parents about the importance of vaccinating children may help in efforts to reach the levels of coverage that will be needed to reach herd immunity. J o u r n a l P r e -p r o o f *Survey weights applied to sample to represent US population by race, ethnicity, sex, education and region. ^Weighted percents are prevalence estimates of US parents reporting they were plan to vaccinate their youngest child, were not willing or were unsure. Ŧp-values from Rao adjusted Pearson Chi-squared tests to compare expected to observed frequencies among groups by characteristic for parent's willingness to vaccinate their youngest child (i.e. whether willing to vaccinate youngest child differed by sex of the child, etc.). §Categories are not presented in the table as they yielded unreliable standard error estimates. J o u r n a l P r e -p r o o f Amercian Academy of Pediatrics (AAP) and Children's Hospital Association. Children and COVID-19: State Data Report Version Clinical and epidemiological characteristics of children with COVID-19 Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 -COVID-NET, 14 States COVID-19 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities SARS-CoV-2 infections in children and young people Severe and fatal forms of COVID-19 in children Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with 2019 Novel Coronavirus (SARS-CoV-2) Infection. Case Rep Pediatr Preliminary evidence on long COVID in children Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US Help Stop the Spread of COVID-19 in Children Summary Document for Interim Clinical Considerations for use of COVID-19 Vaccines Currently Authorized in the United States Preparing for A COVID-19 Vaccine: A Mixed Methods Study of Vaccine Hesitant Parents Model-informed COVID-19 vaccine prioritization strategies by age and serostatus Herd immunity and vaccination of children for COVID-19 Mental health considerations for children quarantined because of COVID-19 Challenges and burden of the Coronavirus 2019 (COVID-19) pandemic for child and adolescent mental health: a narrative review to highlight clinical and research needs in the acute phase and the long return to normality Herd Immunity: Understanding COVID-19 Herd immunity -estimating the level required to halt the COVID-19 epidemics in affected countries Covid Vaccine Hesitancy Drops Among All Americans, New Survey Shows. KFF COVID-19 Vaccine Monitor 2021 COVID Data Tracker: COVID-19 Vaccinations in the United States US Census Bureau (USC). Census QuickFacts Standard defintions: final dispositions of case codes and outcome rates for surveys Parental Hesitancy About Routine Childhood and Influenza Vaccinations: A National Survey Parental Vaccine Hesitancy and Childhood Influenza Vaccination Vaccination Hesitancy in the United States: A Rapid National Assessment Epidemiology of vaccine hesitancy in the United States A Tale of Two Diverse Qualtrics Samples: Information for Online Survey Researchers J&J pause magnifies worry about COVID-19 vaccine hesitancy